Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation.

de la Rica L, Rodríguez-Ubreva J, García M, Islam AB, Urquiza JM, Hernando H, Christensen J, Helin K, Gómez-Vaquero C, Ballestar E.

Genome Biol. 2013;14(9):R99.

2.

5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes.

Klug M, Schmidhofer S, Gebhard C, Andreesen R, Rehli M.

Genome Biol. 2013 May 26;14(5):R46. doi: 10.1186/gb-2013-14-5-r46.

3.

Aldosterone reprograms promoter methylation to regulate αENaC transcription in the collecting duct.

Yu Z, Kong Q, Kone BC.

Am J Physiol Renal Physiol. 2013 Oct 1;305(7):F1006-13. doi: 10.1152/ajprenal.00407.2013. Epub 2013 Aug 7.

4.

Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation.

Luchin A, Suchting S, Merson T, Rosol TJ, Hume DA, Cassady AI, Ostrowski MC.

J Biol Chem. 2001 Sep 28;276(39):36703-10. Epub 2001 Jul 31.

5.

Epigenetic regulation of the metallothionein-1A promoter by PU.1 during differentiation of THP-1 cells.

Suzuki S, Nakano H, Takahashi S.

Biochem Biophys Res Commun. 2013 Apr 12;433(3):349-53. doi: 10.1016/j.bbrc.2013.03.007. Epub 2013 Mar 15.

PMID:
23501100
6.

Early de novo DNA methylation and prolonged demethylation in the muscle lineage.

Tsumagari K, Baribault C, Terragni J, Varley KE, Gertz J, Pradhan S, Badoo M, Crain CM, Song L, Crawford GE, Myers RM, Lacey M, Ehrlich M.

Epigenetics. 2013 Mar;8(3):317-32. doi: 10.4161/epi.23989. Epub 2013 Feb 15.

7.

NF-κB-direct activation of microRNAs with repressive effects on monocyte-specific genes is critical for osteoclast differentiation.

de la Rica L, García-Gómez A, Comet NR, Rodríguez-Ubreva J, Ciudad L, Vento-Tormo R, Company C, Álvarez-Errico D, García M, Gómez-Vaquero C, Ballestar E.

Genome Biol. 2015 Jan 5;16:2. doi: 10.1186/s13059-014-0561-5.

8.

c-Jun is a JNK-independent coactivator of the PU.1 transcription factor.

Behre G, Whitmarsh AJ, Coghlan MP, Hoang T, Carpenter CL, Zhang DE, Davis RJ, Tenen DG.

J Biol Chem. 1999 Feb 19;274(8):4939-46.

9.

Reduced genomic cytosine methylation and defective cellular differentiation in embryonic stem cells lacking CpG binding protein.

Carlone DL, Lee JH, Young SR, Dobrota E, Butler JS, Ruiz J, Skalnik DG.

Mol Cell Biol. 2005 Jun;25(12):4881-91.

10.

GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.

Burda P, Vargova J, Curik N, Salek C, Papadopoulos GL, Strouboulis J, Stopka T.

PLoS One. 2016 Mar 24;11(3):e0152234. doi: 10.1371/journal.pone.0152234. eCollection 2016.

11.

Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b.

Suzuki M, Yamada T, Kihara-Negishi F, Sakurai T, Hara E, Tenen DG, Hozumi N, Oikawa T.

Oncogene. 2006 Apr 20;25(17):2477-88.

PMID:
16331260
12.

The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.

Kwon OH, Lee CK, Lee YI, Paik SG, Lee HJ.

Biochem Biophys Res Commun. 2005 Sep 23;335(2):437-46.

PMID:
16083856
13.

Impaired micro-RNA pathways diminish osteoclast differentiation and function.

Sugatani T, Hruska KA.

J Biol Chem. 2009 Feb 13;284(7):4667-78. doi: 10.1074/jbc.M805777200. Epub 2008 Dec 5.

14.

Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.

Rekhtman N, Radparvar F, Evans T, Skoultchi AI.

Genes Dev. 1999 Jun 1;13(11):1398-411.

15.

DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development.

Fan T, Schmidtmann A, Xi S, Briones V, Zhu H, Suh HC, Gooya J, Keller JR, Xu H, Roayaei J, Anver M, Ruscetti S, Muegge K.

Epigenetics. 2008 May-Jun;3(3):134-42. Epub 2008 May 9.

16.

Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors.

Hu R, Sharma SM, Bronisz A, Srinivasan R, Sankar U, Ostrowski MC.

Mol Cell Biol. 2007 Jun;27(11):4018-27. Epub 2007 Apr 2.

17.

Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states.

Pham TH, Benner C, Lichtinger M, Schwarzfischer L, Hu Y, Andreesen R, Chen W, Rehli M.

Blood. 2012 Jun 14;119(24):e161-71. doi: 10.1182/blood-2012-01-402453. Epub 2012 May 1.

18.

Involvement of PU.1 in NFATc1 promoter function in osteoclast development.

Ishiyama K, Yashiro T, Nakano N, Kasakura K, Miura R, Hara M, Kawai F, Maeda K, Tamura N, Okumura K, Ogawa H, Takasaki Y, Nishiyama C.

Allergol Int. 2015 Jul;64(3):241-7. doi: 10.1016/j.alit.2015.01.006. Epub 2015 Mar 20.

19.

Inhibition of osteoclast differentiation by overexpression of NDRG2 in monocytes.

Kang K, Nam S, Kim B, Lim JH, Yang Y, Lee MS, Lim JS.

Biochem Biophys Res Commun. 2015 Dec 25;468(4):611-6. doi: 10.1016/j.bbrc.2015.10.167. Epub 2015 Nov 4.

PMID:
26546825
20.

DNA methylation: TET proteins-guardians of CpG islands?

Williams K, Christensen J, Helin K.

EMBO Rep. 2011 Dec 23;13(1):28-35. doi: 10.1038/embor.2011.233. Review.

Supplemental Content

Support Center